Nasdaq Prva News Today

Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) CEO Parth Mehrotra sold 12,219 shares of the business’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total transaction of $225,073.98. Following the sale, the chief executive officer now directly owns 261,640 shares of […]

Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) EVP Thomas Bartrum sold 2,252 shares of the business’s stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $41,481.84. Following the sale, the executive vice president now owns 103,862 shares in the […]

Handelsbanken Fonder AB increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 41.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 15,000 shares of the company’s stock after buying an additional 4,400 shares during the quarter. Handelsbanken Fonder AB’s holdings in Privia Health Group were worth $345,000 as […]

Citigroup started coverage on shares of Privia Health Group (NASDAQ:PRVA – Free Report) in a research report report published on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $25.00 target price on the stock. A number of other analysts also recently issued reports on PRVA. JPMorgan Chase & Co. lowered their […]

Privia Health Group (NASDAQ:PRVA – Free Report) had its price objective lowered by JPMorgan Chase & Co. from $38.00 to $30.00 in a research report released on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other equities analysts also recently issued reports on PRVA. Truist Financial […]

Privia Health Group (NASDAQ:PRVA – Get Free Report) had its price target lowered by analysts at Evercore ISI from $26.00 to $25.00 in a report issued on Wednesday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Evercore ISI’s target price points to a potential upside of 13.48% from the company’s current […]

Privia Health Group (NASDAQ:PRVA – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11, Briefing.com reports. The company had revenue of $440.80 million for the quarter, compared to analysts’ expectations of $425.81 million. Privia Health […]

Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […]

Bank of America lowered shares of Privia Health Group (NASDAQ:PRVA – Free Report) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat Ratings reports. Bank of America currently has $21.00 price target on the stock, down from their previous price target of $27.00. PRVA has been the topic […]

Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine analysts that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month […]